Analysts at StockNews.com began coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Get Free Report) in a research report issued to clients and investors on Monday. The brokerage set a “hold” ...
And the best part? Eligible customers can sign up for a 30-day free trial and experience the incredible benefits Prime offers without paying a penny upfront. Prime aims to make your life more ...